Increased MET expression and HGF-dependent invasion under hypoxia has been described years ago and has been subsequently confirmed by other studies conducted in several model systems, including glioblastoma and pancreatic cancer [12–14]. The gene discussed is MET; the disease is familial pancreatic carcinoma.